Overexpression of BIRC3 is associated with glioma progression and aggression and chronic and acute B cell lymphocytic leukemia [55, 56]; it is also a predictor of therapeutic resistance to treatment with irradiation, doxorubicin, and temozolomide [57, 58]. The gene discussed is BIRC3; the disease is glioma.